EPHS Holdings Inc. (OTCQB:STNN) (“EPHS” or the “Company”), together with its joint venture partner, Merritt Valley Cannabis, is pleased to announce its Montreal cultivation plans have commenced, as per Health Canada sales licence regulations and inspections.
The EPHS state-of-the-art facility located in Montreal, Quebec is ready for immediate production and scale. EPHS is commencing with the Health Canada sales license process.
EPHS will continue to scale cannabis production at its Merritt site with the granting of additional Health Canada licenses. Ground breaking is scheduled for early 2019 for phase one of the 30,000 square foot state-of-the-art Cannabis Campus. The campus is expected to produce a supply of 5,500 plus kilograms of cannabis per year by early 2020.
EPHS CEO, Gianfranco Bentivoglio, stated “Our vision is to be unique, and the EPHS business model is built on simplicity and focus. It is our objective to build more efficiently and deliver cannabis to the under-supplied Canadian and global markets.”
Bentivoglio ended by stating “Canadian press ran many articles on supply shortages and long lines, and EPHS’ business and project plans have been developed to address these shortages and demands.”
Having Steve Perry, former Vice President of Energy and Major Projects for The Green Organic Dutchman Holdings Ltd. (US:TGODF) (TSX:TGOD), provides proven experience vital to scaling supply to serve the high demand market. EPHS and Merritt Valley Cannabis’ 1.2 million square foot Cannabis Campus located in Merritt BC will be capable of producing in excess of 100,000 kilograms of cannabis product over the next five years to serve global market demands.
About EPHS Holdings Inc.
EPHS Holdings Inc., together with its joint venture partner, Merritt Valley Cannabis, is a licensed commercial cannabis cultivator engaging in the cultivation, possession, research, processing, sales and distribution of medicinal and recreational cannabis under the laws of the Health Canada ACMPR license.
Certain statements contained in this news release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” are based on expectations, estimates and projections at the time the statements are made, and involve risks and uncertainties, which could cause actual results or events to differ materially from those currently anticipated, including, but not limited to delays, difficulties, changed strategies, or unanticipated factors or circumstances affecting EPHS Holdings, Inc. and its business. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Company to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements found in the Company’s filings with the SEC, including, but not limited to, its Annual Report on Form 10-K, its subsequent Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. The risk factors and other factors noted in the Company’s SEC filings could cause actual results to differ materially from those contained in any forward-looking statement.
About Emerald Plants Health Source
EPHS Holdings Inc.
John Bentivoglio, 1-516-754-7604
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).